Literature DB >> 26989466

Expression of p-STAT3 and vascular endothelial growth factor in MNNG-induced precancerous lesions and gastric tumors in rats.

Xiao-Yan Wang1, Lou-Lei Wang1, Xuan Zheng1, Li-Na Meng1, Bin Lyu1, Hai-Feng Jin1.   

Abstract

AIM: To investigate the dynamic expression of p-signal transducer and activator of transcription 3 (STAT3) and vascular endothelial growth factor (VEGF) in the formation of gastric tumors induced by drinking water containing N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) in Wistar rats.
METHODS: One hundred and twenty Wistar rats were randomly divided into two groups (60 in each group): Control group and Model group. The rats in each group were then randomly divided into three groups (20 in each group): C/M15, C/M25 and C/M40 (15, 25 and 40 represent the number of feeding weeks from termination). Rats in the control group received normal drinking water and rats in the model group received drinking water containing 100 μg/mL MNNG. Stomach tissues were collected at the end of the 15(th), 25(th) and 40(th) week, respectively, for microscopic measurement using hematoxylin and eosin staining. The expression of p-STAT3 and VEGF in different pathological types of gastric tissue, including normal, inflammation, atrophy, hyperplasia and gastric stromal tumor, was observed by immunohistochemistry and Western blot, and the corelation between p-STAT3 and VEGF was analyzed.
RESULTS: (1) The expression of p-STAT3 in tissue with gastritis, atrophy, dysplasia and gastric stromal tumor were significantly increased in the model group compared with the control group (2.5 ± 1.0, 2.75 ± 0.36, 6.2 ± 0.45, 5.67 ± 0.55 vs 0.75 ± 0.36, P = 0.026, 0.035, 0.001, 0.002, respectively); the expression of p-STAT3 in tissue with dysplasia was higher than that in samples with gastritis or atrophy (6.2 ± 0.45 vs 2.5 ± 1.0, P = 0.006; 6.2 ± 0.45 vs 2.75 ± 0.36, P = 0.005, respectively); however, the expression of p-STAT3 in gastritis and atrophy was not significantly different (P > 0.05); (2) the expression of VEGF in tissue with gastritis, atrophy, dysplasia and gastric stromal tumor was significantly increased in the model group compared with normal gastric mucosa; and the expression of VEGF in tissue with dysplasia was higher than that in tissue with inflammation and atrophy (10.8 ± 1.96 vs 7.62 ± 0.25, P = 0.029; 10.8 ± 1.96 vs 6.26 ± 0.76, P = 0.033, respectively); similarly, the expression of VEGF in tissue with gastritis and atrophy was not significantly different (P > 0.05); and (3) the expression of VEGF was positively correlated with p-STAT3.
CONCLUSION: p-STAT3 plays an important role in gastric cancer formation by regulating the expression of VEGF to promote the progression of gastric tumor from gastritis.

Entities:  

Keywords:  Gastric tumor; N-methyl-N’-nitro-N-nitrosoguanidine; Precancerous gastric lesions; Vascular endothelial growth factor; Wistar rat; p-signal transducer and activator of transcription 3

Year:  2016        PMID: 26989466      PMCID: PMC4789616          DOI: 10.4251/wjgo.v8.i3.305

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  38 in total

1.  (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.

Authors:  Bao-He Zhu; Hua-Yun Chen; Wen-Hua Zhan; Cheng-You Wang; Shi-Rong Cai; Zhao Wang; Chang-Hua Zhang; Yu-Long He
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

2.  Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations.

Authors:  M S Wu; C T Shun; C C Wu; T Y Hsu; M T Lin; M C Chang; H P Wang; J T Lin
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

3.  Adding fuel to the fire: STAT3 priming of gastric tumorigenesis.

Authors:  Lee A Denson
Journal:  Gastroenterology       Date:  2006-10       Impact factor: 22.682

Review 4.  Mechanisms of obesity-induced gastrointestinal neoplasia.

Authors:  José O Alemán; Peter R Holt; Leonardo H Eusebi; Luigi Ricciardiello; Kavish Patidar; Arun J Sanyal
Journal:  Gastroenterology       Date:  2013-12-06       Impact factor: 22.682

5.  STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis.

Authors:  Louise M Judd; Karin Bredin; Anastasia Kalantzis; Brendan J Jenkins; Matthias Ernst; Andrew S Giraud
Journal:  Gastroenterology       Date:  2006-07-24       Impact factor: 22.682

6.  The Vienna classification of gastrointestinal epithelial neoplasia.

Authors:  R J Schlemper; R H Riddell; Y Kato; F Borchard; H S Cooper; S M Dawsey; M F Dixon; C M Fenoglio-Preiser; J F Fléjou; K Geboes; T Hattori; T Hirota; M Itabashi; M Iwafuchi; A Iwashita; Y I Kim; T Kirchner; M Klimpfinger; M Koike; G Y Lauwers; K J Lewin; G Oberhuber; F Offner; A B Price; C A Rubio; M Shimizu; T Shimoda; P Sipponen; E Solcia; M Stolte; H Watanabe; H Yamabe
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

7.  Immunohistochemical expression of vascular endothelial growth factor (VEGF) in intestinal type gastric carcinoma.

Authors:  M Raica; L Mogoantă; Anca Maria Cîmpean; Aurora Alexa; S Ioanovici; Cl Mărgăritescu; Daniela Lazăr; D Izvernariu
Journal:  Rom J Morphol Embryol       Date:  2008       Impact factor: 1.033

8.  Chemoprevention of gastric cancer by celecoxib in rats.

Authors:  P J Hu; J Yu; Z R Zeng; W K Leung; H L Lin; B D Tang; A H C Bai; J J Y Sung
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

9.  Magnifying chromoendoscopy combined with immunohistochemical staining for early diagnosis of gastric cancer.

Authors:  Xian-Mei Meng; Yi Zhou; Tong Dang; Xu-Yang Tian; Jie Kong
Journal:  World J Gastroenterol       Date:  2013-01-21       Impact factor: 5.742

10.  Relationship between expression and prognostic ability of PTEN, STAT3 and VEGF-C in colorectal cancer.

Authors:  Canhui Jin; Aihong Wang; Jianmin Chen; Xiaomin Liu; Gongping Wang
Journal:  Exp Ther Med       Date:  2012-07-31       Impact factor: 2.447

View more
  4 in total

1.  Gastro-Protective Effects of Calycosin Against Precancerous Lesions of Gastric Carcinoma in Rats.

Authors:  Danyan Li; Luqing Zhao; Yuxin Li; Xiuhong Kang; Shengsheng Zhang
Journal:  Drug Des Devel Ther       Date:  2020-06-09       Impact factor: 4.162

2.  Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers.

Authors:  Samantha M Y Chen; Vince Popolizio; Rachel A Woolaver; Huaibin Ge; Alexandra L Krinsky; Jessy John; Etienne Danis; Yao Ke; Yonatan Kramer; Li Bian; Andrew G Nicklawsky; Dexiang Gao; Silvia Liu; Zhangguo Chen; Xiao-Jing Wang; Jing H Wang
Journal:  J Exp Clin Cancer Res       Date:  2022-04-02

Review 3.  STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Sima Orouei; Vahideh Zarrin; Ebrahim Rahmani Moghadam; Amirhossein Zabolian; Shima Mohammadi; Kiavash Hushmandi; Yashar Gharehaghajlou; Pooyan Makvandi; Masoud Najafi; Reza Mohammadinejad
Journal:  Biology (Basel)       Date:  2020-06-12

4.  Epigallocatechin Gallate Protects against MNNG-Induced Precancerous Lesions of Gastric Carcinoma in Rats via PI3K/Akt/mTOR Pathway.

Authors:  Feiye Zhu; Yanli Xu; Jieli Pan; Meiya Li; Fangming Chen; Guanqun Xie
Journal:  Evid Based Complement Alternat Med       Date:  2021-02-05       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.